← All indications

Hyper-IgM Immunodeficiency Syndrome, Type 1

An X-linked hyper-IgM immunodeficiency subtype resulting from mutation in the gene encoding CD40 LIGAND.

Drugs by status

Organizations

Organization Involved with Phase 4 Indications (1)

Organization Involved with Phase 2 Indications (1)

Organization Involved with Other Experimental Indications (1)